Immunotherapy for type 1 diabetes deemed safe in first US trial
In the first U.S. safety trial of a new form of immunotherapy for type 1 diabetes (T1D), led by UC San Francisco scientists and physicians, patients experienced no serious adverse reactions after receiving infusions of as ...
Nov 25, 2015
0
1684